Episode
Fixed-Duration Therapy Changes CLL Treatment | Health and Fitness News
- Published
- Jul 18, 2026
- Duration seconds
- 119
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/1586df6d377e9fd5
Actions
POST https://stenobird.com/v1/public/podcasts/health-news-today-2-min-news-the-daily-news-now-7685759/episodes/fixed-duration-therapy-changes-cll-treatment-health-and-fitness-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/fixed-duration-therapy-changes-cll-treatment-health-and-fitness-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
CLL treatment is undergoing a major shift with fixed-duration therapy—patients now take meds for a set time (usually 1-2 years) instead of lifelong treatment, offering a clear endpoint, fewer side effects, and potentially delaying drug resistance. While promising, it’s not for all—doctors evaluate genetic markers to determine eligibility, and drugs like venetoclax require close monitoring. Common regimens combine venetoclax with monoclonal antibodies or BTK inhibitors, lasting 12-14 months, with ongoing research expanding options. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/1586df6d377e9fd5